3E0DXHZ Introduction of Radioactive Substance into Mouth and Pharynx, External Approach
Billable / valid for submission ICD10PCS Release FY2026-APR
Short description: Introduce of Radioact Subst into Mouth/Phar, Extern Approach
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | 2026-03-31 | Introduction of Radioactive Substance into Mouth and Pharynx, External Approach | yes |
| FY2026-APR | 2026-04-01 | current | Introduction of Radioactive Substance into Mouth and Pharynx, External Approach | yes |
Related codes in 3E0
- 3E0 Administration, Physiological Systems and Anatomical Regions, Introduction
- 3E00X05 Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach
- 3E00X0M Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach
- 3E00X28 Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach
- 3E00X29 Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach
- 3E00X3Z Introduction of Anti-inflammatory into Skin and Mucous Membranes, External Approach
- 3E00X4Z Introduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach
- 3E00XBZ Introduction of Anesthetic Agent into Skin and Mucous Membranes, External Approach
- 3E00XGC Introduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach
- 3E00XKZ Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
- 3E00XMZ Introduction of Pigment into Skin and Mucous Membranes, External Approach
- 3E00XNZ Introduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach
- 3E00XTZ Introduction of Destructive Agent into Skin and Mucous Membranes, External Approach
- 3E0102A Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach
- 3E01305 Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
- 3E0130M Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
- 3E01328 Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach
- 3E01329 Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach
- 3E0132A Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach
- 3E0133Z Introduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach